Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISIS 546254 for Preventive Treatment of Chronic Migraine
NCT03108469Phase 2Completed
- Start
- Aug 2017
- Primary completion
- Apr 2019
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 2 trial of IONIS-PKKRx in chronic migraine. Started Aug 2017; status: completed.
02
Drugs
IONIS-PKKRx
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT03108469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03108469.